<!doctype html>
<html lang="es">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>Spanish Daily – Nov 19, 2025</title>
<meta name="color-scheme" content="light dark" />
<style>
  :root { --maxw: 800px; }
  html { -webkit-text-size-adjust: 100%; }
  body { margin: 0; padding: 0; font-family: system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial,sans-serif,Apple Color Emoji,Segoe UI Emoji; line-height: 1.6; font-size: 18px; }
  header, main, footer { max-width: var(--maxw); margin: 0 auto; padding: 16px; }
  header { padding-top: 20px; }
  h1 { font-size: 1.4rem; margin: 0 0 8px; }
  .subtle { opacity: 0.72; font-size: 0.95rem; }
  .card { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 14px; margin: 12px 0; }
  .tip-word { all: unset; display: inline; position: relative; cursor: pointer;
    text-decoration: underline dotted; text-underline-offset: 3px;
    padding: 0 .1em; border-radius: .35em; background: rgba(255,235,59,.28); }
  .tooltip { position: fixed; padding: .48rem .6rem; background: rgba(0,0,0,.88); color: #fff;
    border-radius: .55rem; font-size: .95rem; line-height: 1.3; max-width: min(90vw, 26rem);
    z-index: 9999; box-shadow: 0 6px 18px rgba(0,0,0,.18); }
  .content { white-space: pre-line; }
  .card { margin-bottom: 1.5em; line-height: 1.6; }
  strong { display: inline-block; margin-top: .35em; }
  details { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 12px; }
  details + details, details + .card { margin-top: 12px; }
  summary { cursor: pointer; font-weight: 600; }
  summary::marker { content: ""; }
  summary::after { content: " ▸"; }
  details[open] summary::after { content: " ▾"; }
  .debug { position: fixed; bottom: 8px; right: 8px; font-size: 12px; opacity: .6; }
</style>
</head>
<body>
  <header>
    <h1>Spanish Daily</h1>
    <div class="subtle">Toca una palabra subrayada para ver la traducción. Toca fuera para cerrar.</div>
  </header>

  <main>
    <!-- Spanish first -->
    <section class="card content">
STORY

Medicamentos nuevos como los gepantes y los ditanes <span title="are good for">son buenos para</span> tratar las migrañas. <span title="They are useful for">Son útiles para</span> personas que <span title="cannot use">no pueden usar</span> o <span title="do not get better with">no mejoran con</span> los tratamientos habituales. Los gepantes <span title="help stop">ayudan a detener</span> las migrañas sin <span title="make blood vessels contract">hacer que los vasos sanguíneos se contraigan</span>. Esto <span title="is good for">es bueno para</span> personas con problemas cardíacos. The New England Journal of Medicine dice que <span title="they work well">funcionan bien</span> y <span title="are safe">son seguros</span>. Los ditanes, como la lasmiditán, tampoco <span title="make blood vessels contract">hacen que los vasos sanguíneos se contraigan</span>. JAMA Neurology dice que <span title="they help reduce">ayudan a disminuir</span> el dolor de la migraña y otros síntomas. La mayoría de las personas <span title="can take">puede tomar</span> gepantes y ditanes sin problemas. Algunos <span title="may feel">pueden sentir</span> mareo o cansancio, pero <span title="it is not intense">no es intenso</span>. <span title="They are safer">Son más seguros</span> para personas con problemas cardíacos. <span title="We still do not have">Todavía no tenemos</span> todos los datos de 2025, pero <span title="more and more">cada vez más</span> médicos <span title="use these medications">usan estos medicamentos</span>. Más personas <span title="can access them">pueden acceder a ellos</span> porque las compañías de seguros <span title="cover them">los cubren</span>. <span title="We do not know the cost">No sabemos el costo</span> según la American Headache Society. Los médicos <span title="should consider">deben considerar</span> el uso de gepantes y ditanes para personas con migrañas, especialmente si <span title="cannot use">no pueden usar</span> los tratamientos habituales.

---
DIALOGUE

Narrator: Hoy, el médico <span title="talks about">habla sobre</span> nuevos medicamentos para la migraña.
Physician: Hola. ¿Cómo <span title="are your migraines">están tus migrañas</span>?
Patient: <span title="I still have">Todavía tengo</span> muchos dolores de cabeza. Mi medicina anterior <span title="does not help me">no me ayuda</span>.
Physician: Entiendo. <span title="There are new medications">Hay medicamentos nuevos</span> llamados gepantes y ditanes.
Patient: ¿<span title="Are they like">Son como</span> mi medicina anterior?
Physician: No, <span title="they work differently">funcionan de manera diferente</span>. <span title="They do not make">No hacen que</span> tus vasos sanguíneos se contraigan.
Patient: ¿Eso <span title="is safer for">es más seguro para</span> personas con problemas cardíacos?
Physician: Sí, <span title="it is safer">es más seguro</span> que algunos medicamentos antiguos.
Patient: ¿Cuáles <span title="are the side effects">son los efectos secundarios</span>?
Physician: Algunas personas <span title="feel tired">sienten cansancio</span> o mareo, pero <span title="it is not strong">no es fuerte</span>.
Patient: ¿<span title="Can I try">Puedo probar</span> estos medicamentos?
Physician: Sí, <span title="I think it is">creo que es</span> una buena idea para ti.
Patient: ¿Mi seguro <span title="will cover it">lo cubrirá</span>?
Physician: Ahora muchos planes de seguro <span title="cover it">lo cubren</span>. <span title="We can check it">Podemos verificarlo</span> por ti.

    </section>

    <!-- English below -->

    <details open class="card content">
      <summary>INGLÉS</summary>
STORY

New medicines like gepants and ditans are good for treating migraines. They are good for people who can't use or don't get better with usual treatments. Gepants help stop migraines without making blood vessels tighter. This is good for people with heart problems. The New England Journal of Medicine says they work well and are safe. Ditans, like lasmiditan, also don't make blood vessels tighter. JAMA Neurology says they help lessen migraine pain and other symptoms. Most people can take gepants and ditans without problems. Some might feel dizzy or tired, but not too much. They are safer for people with heart problems. We don't have all the facts from 2025 yet, but more and more doctors are using these medicines. More people can get them because insurance companies are paying for them. We don't know the cost from the American Headache Society. Doctors should think about using gepants and ditans for people with migraines, especially if they can't use usual treatments.

---
DIALOGUE

Narrator: Today, the doctor talks about new migraine medicines. 
Physician: Hello. How are your migraines? 
Patient: I still have many headaches. My old medicine does not help. 
Physician: I understand. There are new medicines called gepants and ditans. 
Patient: Are these like my old medicine? 
Physician: No, they work differently. They do not make your blood vessels tight. 
Patient: Is that safer for people with heart problems? 
Physician: Yes, it is safer than some older medicines. 
Patient: What are the side effects? 
Physician: Some people feel tired or dizzy, but it is not strong. 
Patient: Can I try these medicines? 
Physician: Yes, I think it is a good idea for you. 
Patient: Will my insurance pay for it? 
Physician: Many insurance plans pay now. We can check for you.
    </details>
  </main>

  <footer class="subtle">
    <div>© Nov 19, 2025 · Mezra.AI · Practica todos los días.</div>
  </footer>

  <div class="debug">EN: found</div>

  <!-- NEW: light cache-busting helper -->
  <script>
  (function() {
    // 1. Get the version tag from the URL, if present (?v=SHA...)
    var params = new URLSearchParams(window.location.search);
    var version = params.get('v');

    // 2. Read the debug indicator already inside your page
    var debug = document.querySelector('.debug');
    var debugText = debug ? debug.textContent.trim() : '';

    // 3. Heuristic: if version is missing or debug looks suspicious, force a one-time reload
    var isLikelyStale =
      !version ||
      debugText === '' ||
      debugText.indexOf('placeholder') !== -1 ||
      debugText.indexOf('not found') !== -1 ||
      debugText.length < 3;

    if (isLikelyStale) {
      if (!params.get('forceReload')) {
        params.set('forceReload', '1');
        var newUrl = window.location.pathname + '?' + params.toString();
        window.location.replace(newUrl);
      }
    }
  })();
  </script>

  <!-- Existing tooltip behavior -->
  <script>
  (function () {
    document.querySelectorAll('.content').forEach(function(container) {
      container.querySelectorAll('span[title]').forEach(function(span) {
        var text = span.textContent;
        var tip  = span.getAttribute('title');
        var btn  = document.createElement('button');
        btn.className = 'tip-word'; btn.type = 'button';
        btn.textContent = text; btn.setAttribute('data-tip', tip);
        span.replaceWith(btn);
      });
    });

    var openTip = null;
    function closeTip(){ if(openTip){ openTip.remove(); openTip = null; } }
    function showTip(target){
      closeTip();
      var tipText = target.getAttribute('data-tip') || '';
      if(!tipText) return;
      var bubble = document.createElement('div');
      bubble.className = 'tooltip';
      bubble.textContent = tipText;
      document.body.appendChild(bubble);
      var r = target.getBoundingClientRect();
      var m = 8, vw = innerWidth, vh = innerHeight;
      var rect = bubble.getBoundingClientRect();
      var tw = rect.width;
      var th = rect.height;
      var left = r.left, top = r.bottom + m;
      if (left + tw + m > vw) left = Math.max(m, vw - tw - m);
      if (left < m) left = m;
      if (top + th + m > vh) top = Math.max(m, r.top - th - m);
      bubble.style.left = left + 'px';
      bubble.style.top  = top + 'px';
      openTip = bubble;
    }

    document.addEventListener('click', function(e) {
      var word = e.target.closest('.tip-word');
      if (word){ if (openTip) closeTip(); else showTip(word); e.stopPropagation(); }
      else { closeTip(); }
    });
    document.addEventListener('touchstart', function(e) {
      if (!e.target.closest('.tip-word')) closeTip();
    }, { passive: true });
    addEventListener('scroll', closeTip, { passive: true });
    addEventListener('resize', closeTip);
    document.addEventListener('keydown', function(e) { if (e.key === 'Escape') closeTip(); });
  })();
  </script>
</body>
</html>